Motilal Oswal has reaffirmed a BUY call on real estate major Lodha Developers, confident about its robust growth trajectory and strong market positioning.
Motilal Oswal Financial Services has reiterated its BUY recommendation for Sun Pharma, assigning a 12-month target price of Rs 1,960, with the stock currently trading at Rs 1,690.
Motilal Oswal, a leading research house, has reiterated a BUY call on Mahindra & Mahindra (M&M) with a target price of Rs 4,122, citing robust earnings, margin expansion, and strong growth
Motilal Oswal Financial Services has reiterated a BUY rating on Rural Electrification Corporation (RECL), emphasizing stable asset quality, consistent earnings growth, and a robust future loan book